“Repurposing FDA-Approved Antimalarial Drugs: Mefloquine as a Promising Multi-Targeted Therapeutic for Non-Small Cell Lung Cancer: Repurposing Antimalarials: Mefloquine for Multi-Targeted NSCLC Therapy” (2025) Indian Journal of Chemistry (IJC), 64(7), pp. 730–745. doi:10.56042/ijc.v64i7.16642.